Primary ACL Reconstruction in Patient Over 40 Years: Allograft Versus Autograft
Launched by UNIVERSITÀ VITA-SALUTE SAN RAFFAELE · Sep 2, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective two different types of tendon grafts are for patients over 40 years old who have had surgery to reconstruct a torn ACL (an important ligament in the knee). The study aims to compare the success rates of using allograft tendons (which come from a donor) versus autograft tendons (which come from the patient’s own body) in preventing graft failure, which means whether the new tendon holds up over time. Researchers want to see if there are differences in how well patients recover and function with each type of graft after at least two years.
To participate in this study, individuals must be 40 years old or older and should have had primary ACL reconstruction using either type of tendon. They also need to be able to give their consent to join the trial. However, some people will not be eligible, such as those with multiple ligament injuries or significant knee issues. Participants can expect to be followed for two years to assess their recovery and the performance of the grafts. This study is important because it will help doctors understand which type of graft works better for older patients, potentially leading to improved treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant is willing and able to give informed consent for participation in the study.
- • Male and female patients of fertile age can be recruited
- • Patients aged 40 years old and above, and 2 years minimum of follow-up
- • Patients that underwent primary ACL reconstruction with allograft an autograft tendons
- Exclusion Criteria:
- • Multiligamentous lesion
- • Meniscal tear leading to subtotal or total meniscectomy or meniscal graft
- • Indication for major cartilage restoration or resurfacing
- • Ipsilateral knee fractures
- • History of ligament injury
- • Concomitant extracapsular procedures
- • Ipsilateral or contralateral knee surgeries
About Università Vita Salute San Raffaele
Università Vita-Salute San Raffaele is a prestigious Italian academic institution renowned for its commitment to advancing healthcare through innovative research and education. Located in Milan, it integrates cutting-edge scientific inquiry with clinical practice, fostering interdisciplinary collaboration among healthcare professionals. The university is dedicated to improving patient outcomes and public health by conducting rigorous clinical trials that adhere to the highest ethical standards. Its focus spans various medical fields, leveraging state-of-the-art facilities and a strong network of partnerships to drive advancements in medical science and contribute to the global healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Milan, Italy/Milan, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported